Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$2.77 - $3.38 $2,770 - $3,380
1,000 Added 100.0%
2,000 $5,000
Q2 2022

Aug 12, 2022

BUY
$2.35 - $4.47 $2,350 - $4,470
1,000 New
1,000 $4,000
Q4 2018

Feb 14, 2019

SELL
$7.35 - $11.7 $9,121 - $14,519
-1,241 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$7.88 - $16.45 $2,639 - $5,510
-335 Reduced 21.26%
1,241 $10,000
Q4 2017

Feb 14, 2018

BUY
$10.37 - $12.85 $16,343 - $20,251
1,576
1,576 $20,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $296M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.